ArticlePloS one2024

Evaluation of risk factors for 14-day and 30-day mortality among treatment regimens against Pseudomonas aeruginosa resistant to carbapenem but susceptible to traditional antipseudomonal non-carbapenem β-lactam agents.

Suvadee Supreeyasakon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.